In conclusion, detection of Ezrin and E-cadherin expression in cervical smears, could be a potential prognostic marker for identifying cervical lesions with high-risk of progression to invasive cervical cancer, and may help on the selection of an appropriate therapy or avoid unnecessary treatment; a larger number of samples and a follow-up study will help to confirm this proposal. This evidence concerns the gene CDH1 and cervical cancer.